Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 1174930 records

$20,000.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

CIHR Fellowship

Agreement Number:

177340

Duration: from Apr 1, 2024 to Jul 31, 2024
Description:

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic health research trainees;
• To provide a reliable supply of highly skilled and qualified researchers.

Organization: Canadian Institutes of Health Research
Program Name: Training and Career Support
Location: Boston, US

$4,846,275.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175217

Duration: from Apr 1, 2024 to Mar 31, 2029
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Québec, Quebec, CA G1V 0A6

$888,165.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175286

Duration: from Apr 1, 2024 to Mar 31, 2027
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Montreal, Quebec, CA H3A 0G4

$459,000.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175332

Duration: from Apr 1, 2024 to Mar 31, 2028
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Edmonton, Alberta, CA T6G 2E1

$963,900.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175048

Duration: from Apr 1, 2024 to Mar 31, 2029
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Toronto, Ontario, CA M5G 1X8

$1,374,999.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Team Grant: Improving Diagnosis for Rare Disease Patients

Agreement Number:

177036

Duration: from Apr 1, 2024 to Mar 31, 2027
Description:

The specific objectives of this funding opportunity are to:

• Generate high quality evidence required to optimize the RD diagnosis pathway in Canada;
• Evaluate the health outcomes associated with RDs via the ‘genomics first’ diagnosis pathway compared to the current approach (i.e., genomic testing performed later);
• Determine the economic impact to the health care system for the ‘genomics first’ diagnosis pathway and compare to current diagnostic pathways for RDs;
• Evaluate the socioeconomic and psychological impacts of delays in the diagnosis on patients/families with RDs from a diversity of population groups and communities in Canada using the ‘genomics first’ diagnostic paradigm as a comparator; and,
• Mobilize knowledge to facilitate the implementation, scale and spread of best practices for diagnosing RDs in Canada.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Kingston, Ontario, CA K7L 3N6

$1,193,400.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175245

Duration: from Apr 1, 2024 to Mar 31, 2029
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Toronto, Ontario, CA M5G 1X8

$990,675.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Project Grant

Agreement Number:

175376

Duration: from Apr 1, 2024 to Mar 31, 2029
Description:

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

Organization: Canadian Institutes of Health Research
Program Name: Investigator-Initiated Research
Location: Edmonton, Alberta, CA T6G 2E1

$1,374,619.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Team Grant: Improving Diagnosis for Rare Disease Patients

Agreement Number:

177038

Duration: from Apr 1, 2024 to Mar 31, 2027
Description:

The specific objectives of this funding opportunity are to:

• Generate high quality evidence required to optimize the RD diagnosis pathway in Canada;
• Evaluate the health outcomes associated with RDs via the ‘genomics first’ diagnosis pathway compared to the current approach (i.e., genomic testing performed later);
• Determine the economic impact to the health care system for the ‘genomics first’ diagnosis pathway and compare to current diagnostic pathways for RDs;
• Evaluate the socioeconomic and psychological impacts of delays in the diagnosis on patients/families with RDs from a diversity of population groups and communities in Canada using the ‘genomics first’ diagnostic paradigm as a comparator; and,
• Mobilize knowledge to facilitate the implementation, scale and spread of best practices for diagnosing RDs in Canada.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Ottawa, Ontario, CA K1H 8L1

$1,598,238.00

Apr 1, 2024

Individual or sole proprietorship

Agreement:

Team Grant: Improving Health and Admin Data and Monitor Rare Diseases

Agreement Number:

178409

Duration: from Apr 1, 2024 to Mar 31, 2028
Description:

The specific objectives of this funding opportunity are to:

• Demonstrate the feasibility of tracking rare diseases and conducting prospective studies in this field within the Canadian health care systems;
• Increase cross-jurisdictional collaboration and data sharing amongst hospitals;
• Prospectively assess the impact of mortality, co-morbidities, hospital usage, other health system usage, and total direct cost of rare diseases to the health care system; and,
• Facilitate the establishment of patient registries for potential enrollment by a diversity of people in Canada in clinical trials and to enable patient and caregiver peer-to-peer contact.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Calgary, Alberta, CA T2N 1N4